HLS Therapeutics Inc T.HLS

Alternate Symbol(s): HLTRF

HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally. The company offers Clozaril (clozapine tablets), an atypical antipsychotic to manage symptoms of treatment-resistant schizophrenia; CSAN Pronto device, which enhances and simplifies the mandatory safety blood monitoring process for patients that are prescribed Clozaril; Nilemdo, a bempedoic acid product for cardiovascular risk reduction; Nexlizet, a bempedoic acid and ezetimibe product for cardiovascular risk reduction; and Vascepa, an icosapent ethyl capsule for the treatment of cardiovascular disease. It also distributes MyCare psychiatry lab assays, which are a line of tests that can be processed on analyzers used in laboratory systems to measure the blood levels of the most common antipsychotic drugs, including clozapine, risperidone, quetiapine, arip...

TSX:HLS - Post by User

HLS Therapeutics Inc

<< Previous

Bullboard Posts

Next >>

(7)
•••

Post by screamer99on Feb 06, 2024 12:24pm

394 Views

Post# 35865513

BC Drug Plan

Discussion boards are dead everywhere I can see, but the reimbursement from BC is big news.

Last March, when it was announced that discussions were ongoing, this stock fell from $8 to where it is now.

I would think the Alberta reimbursement will follow at some point this year.

Earnings may be flat for the next couple of quarters, but can't help but think this thing will be a few dollars higher by next summer.

Time will tell.

<< Previous

Bullboard Posts

Next >>

Powering next-gen electrification: Inside Québec’s emerging graphite opportunity